• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Syndax Pharma (NQ: SNDX )

    20.71 +0.05 (+0.24%)
    Streaming Delayed Price Updated: 1:17 PM EDT, Aug 29, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 230,909
    Open 20.79
    Bid (Size) 20.70 (2)
    Ask (Size) 20.74 (5)
    Prev. Close 20.66
    Today's Range 20.62 - 21.00
    52wk Range 11.21 - 25.34
    Shares Outstanding 69,484,053
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    FDA Approves Incyte/Syndax Partnered Drug For Chronic Graft-Versus-Host Disease, A Post-Transplant Complication
    The FDA has approved Incyte and Syndax Pharmaceuticals' Niktimvo for chronic graft-versus-host disease in patients after at least two prior therapies, providing new hope for those with this serious... 
    Via Benzinga
    Exposures Product Safety
    Incyte and Syndax Announce U.S. FDA Approval of Niktimvo™ (axatilimab-csfr) for the Treatment of Chronic Graft-Versus-Host Disease (GVHD)
    From Incyte and Syndax Pharmaceuticals
    Via Business Wire

    Performance

    YTD
    -5.26%
    -5.26%
    1 Month
    -5.82%
    -5.82%
    3 Month
    +5.02%
    +5.02%
    6 Month
    -13.27%
    -13.27%
    1 Year
    +8.43%
    +8.43%

    More News

    Read More
    Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Directors
    From Sagimet Biosciences Inc.
    Via GlobeNewswire
    Syndax Pharmaceuticals: Q4 Earnings Insights
    Via Benzinga
    Earnings Scheduled For February 27, 2024
    Via Benzinga
    Earnings Preview: Syndax Pharmaceuticals
    Via Benzinga
    Earnings Outlook For Syndax Pharmaceuticals
    Via Benzinga
    3 Biotech Stocks That Could Make Your Summer Unforgettable
    Via InvestorPlace
    Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies
    Via FinancialNewsMedia
    Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger
    From Pyxis Oncology
    Via GlobeNewswire
    Analyst Ratings for Syndax Pharmaceuticals
    Via Benzinga
    Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies
    From FN Media Group LLC
    Via GlobeNewswire
    Why Ooma Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    SNDX Stock Earnings: Syndax Pharmaceuticals Beats EPS for Q1 2024
    Via InvestorPlace
    Is The Stock Market Ready To Plunge? The Warning Signs Are Here...
    Via Talk Markets
    What's Going On With Leukemia-Focused Syndax Pharmaceuticals Stock Today?
    Via Benzinga
    Incyte and Syndax Present Additional Data from Positive AGAVE-201 Trial at ASH Plenary Session Showing Axatilimab Efficacy Including Durable Responses in Chronic Graft-Versus-Host Disease
    From Incyte and Syndax Pharmaceuticals
    Via Business Wire
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2023
    Via Benzinga
    What's Going On With Syndax Pharmaceuticals Stock Monday?
    Via Benzinga
    Earnings Scheduled For November 2, 2023
    Via Benzinga
    Stocks That Hit 52-Week Lows On Thursday
    Via Benzinga
    Why AERWINS Technologies Shares Are Trading Higher By Around 90%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Why SeaStar Medical Holding Shares Are Trading Higher By Around 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.